VX-993

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for VX-993, covering 2024-07-12 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy [Phase 2]